
Green Sands Equity
220 Montgomery St Ste 468, San Francisco, CA, 94104, United States
Overview
Investment portfolio
| NAME | DATE | SIZE | |
|---|---|---|---|
Venus Aerospace | Jul 2026Participated | $91 MSeries B | |
iSono Health | Jan 2026Participated | $15 MOther Equity | |
Axyon AI | Apr 2025Participated | $5 MOther Equity | |
TreQ Global | Oct 2024Participated | $5 MSeed | |
Vectara | Jul 2024Participated | $25 MSeries A | |
Elve | Feb 2024Participated | $15 MSeries A | |
Stepful | Feb 2024Participated | $12 MSeries A | |
Paradromics | Jun 2023Participated | $33 MSeries A | |
ArsenalBio | Sep 2022Participated | $220 MSeries B | |
Colossal Biosciences | Mar 2022Participated | $60 MSeries A | |
ReViral | Aug 2020Participated | $44 MSeries C | |
Venus Aerospace | Jul 2026Participated | $91 MSeries B | |
iSono Health | Jan 2026Participated | $15 MOther Equity | |
Axyon AI | Apr 2025Participated | $5 MOther Equity | |
TreQ Global | Oct 2024Participated | $5 MSeed | |
Vectara | Jul 2024Participated | $25 MSeries A | |
Elve | Feb 2024Participated | $15 MSeries A | |
Stepful | Feb 2024Participated | $12 MSeries A | |
Paradromics | Jun 2023Participated | $33 MSeries A | |
ArsenalBio | Sep 2022Participated | $220 MSeries B | |
Colossal Biosciences | Mar 2022Participated | $60 MSeries A | |
ReViral | Aug 2020Participated | $44 MSeries C |
Insights
Time horizon
View by
Deal Distribution
| Round type | Led deals | Participated deals |
|---|---|---|
| Seed | 0 | 1 |
| Series A | 0 | 5 |
| Series B | 0 | 2 |
| Series C+ | 0 | 1 |
| Other Equity | 0 | 2 |
Monthly Deal Activity
| Month | Deals |
|---|---|
| Aug '20 | 1 |
| Sep '20 | 0 |
| Oct '20 | 0 |
| Nov '20 | 0 |
| Dec '20 | 0 |
| Jan '21 | 0 |
| Feb '21 | 0 |
| Mar '21 | 0 |
| Apr '21 | 0 |
| May '21 | 0 |
| Jun '21 | 0 |
| Jul '21 | 0 |
| Aug '21 | 0 |
| Sep '21 | 0 |
| Oct '21 | 0 |
| Nov '21 | 0 |
| Dec '21 | 0 |
| Jan '22 | 0 |
| Feb '22 | 0 |
| Mar '22 | 1 |
| Apr '22 | 0 |
| May '22 | 0 |
| Jun '22 | 0 |
| Jul '22 | 0 |
| Aug '22 | 0 |
| Sep '22 | 1 |
| Oct '22 | 0 |
| Nov '22 | 0 |
| Dec '22 | 0 |
| Jan '23 | 0 |
| Feb '23 | 0 |
| Mar '23 | 0 |
| Apr '23 | 0 |
| May '23 | 0 |
| Jun '23 | 1 |
| Jul '23 | 0 |
| Aug '23 | 0 |
| Sep '23 | 0 |
| Oct '23 | 0 |
| Nov '23 | 0 |
| Dec '23 | 0 |
| Jan '24 | 0 |
| Feb '24 | 2 |
| Mar '24 | 0 |
| Apr '24 | 0 |
| May '24 | 0 |
| Jun '24 | 0 |
| Jul '24 | 1 |
| Aug '24 | 0 |
| Sep '24 | 0 |
| Oct '24 | 1 |
| Nov '24 | 0 |
| Dec '24 | 0 |
| Jan '25 | 0 |
| Feb '25 | 0 |
| Mar '25 | 0 |
| Apr '25 | 1 |
| May '25 | 0 |
| Jun '25 | 0 |
| Jul '25 | 0 |
| Aug '25 | 0 |
| Sep '25 | 0 |
| Oct '25 | 0 |
| Nov '25 | 0 |
| Dec '25 | 0 |
| Jan '26 | 1 |
| Feb '26 | 0 |
| Mar '26 | 0 |
| Apr '26 | 0 |
| May '26 | 0 |
| Jun '26 | 0 |
| Jul '26 | 1 |
| Aug '26 | 0 |
| Sep '26 | 0 |
| Oct '26 | 0 |
Sector Breakdown
A deal can appear in multiple sectors, so sector totals may overlap. Capital represents disclosed total round sizes, not fund cheque sizes.
| Sector | Deals |
|---|---|
| Health & Life Sciences | 6 |
| AI & Machine Learning | 3 |
| Enterprise Software | 2 |
| Space & Frontier Tech | 2 |
| Consumer & Lifestyle | 2 |
| Hardware & Robotics | 2 |
| Manufacturing | 2 |
| Education & Workforce | 1 |
| Government & Defense | 1 |
| Clean Energy & Sustainability | 1 |
| Transportation & Logistics | 1 |
| Networks, Cloud & Communication | 1 |
| Fintech | 1 |
| Professional Services | 1 |
| Developer Tools | 1 |
Deal Size Distribution
Undisclosed round sizes are excluded. Capital represents total round sizes, not fund cheque sizes.
| Round size band (USD) | Deals |
|---|---|
| <$5M | 0 |
| $5M-$10M | 2 |
| $10M-$25M | 3 |
| $25M-$50M | 3 |
| $50M-$100M | 2 |
| $100M-$250M | 1 |
| $250M-$500M | 0 |
| $500M-$1B | 0 |
| $1B+ | 0 |
Deals By Geography
Top 2 of 2 regions; European countries are grouped as Europe.
| Region | Deals |
|---|---|
| United States | 9 |
| Europe | 2 |
Co-Investors
Bubble size = shared deals
Click a bubble to open that fund in a new tab.
Shows up to 20 co-investors ranked by shared deals. Deals may be shared with multiple funds, so rows overlap. Capital is total round size, not fund cheque size.
| Co-investor | Shared deals |
|---|---|
| Draper Associates | 3 |
| Lockheed Martin Ventures | 2 |
| 01 Advisors | 1 |
| AlleyCorp | 1 |
| Alumni Ventures | 1 |
| Andera Partners | 1 |
| Animal Capital | 1 |
| Animoca Brands | 1 |
| At One Ventures | 1 |
| Bold Capital | 1 |
| Boost VC | 1 |
| Brace Pharma Capital | 1 |
| Breyer Capital | 1 |
| Bristol Myers Squibb | 1 |
| Builders VC | 1 |
| Byers Capital | 1 |
| Cambium Capital | 1 |
| CDP Venture Capital | 1 |
| Company Ventures | 1 |
| CR-CP Life Science Fund | 1 |
Investment Strategy
| Category | Deals (count) | Share (%) |
|---|---|---|
| Led | 0 | 0% |
| Participating | 11 | 100% |
| Category | Deals (count) | Share (%) |
|---|---|---|
| Single-lead | 0 | 0% |
| Co-led | 0 | 0% |
Lead dynamics requires at least one led deal in this range